Contrast agents for myocardial perfusion imaging

Details for Australian Patent Application No. 2005214898 (hide)

International Classifications

Event Publications

31 August 2006 PCT application entered the National Phase

PCT publication WO2005/079391 Priority application(s): WO2005/079391

23 December 2010 Assignment before Grant

Bristol-Myers Squibb Pharma Company The application has been assigned to Lantheus Medical Imaging, Inc. 2006

6 January 2011 Application Accepted

Published as AU-B-2005214898

14 April 2011 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 30 Mar 2011. Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000

4 August 2011 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 30 Mar 2011

11 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.